[Allogeneic segmental heterotopic pancreas transplantation in the dog with reference to various drainage technics]. 1985

O Abri, and D Lorenz, and H Lippert, and F Kühn

In 35 pancreatectomized dogs, the donor pancreatic tail was transplanted by end-to-side anastomoses between the portal vein and the celiac axis to the femoral vessels of the host. To influence the exocrine pancreas secretion of the graft we applied different methods of drainage of the pancreatic duct: open drainage to the abdominal cavity (Group I, n = 15), occlusion of the duct by Neoprene (Group II, n = 12) and by Ethibloc (Group III, n = 8). Main complications were rejection crisis and pancreatitis. Segmental pancreas allografts were rejected in group I within about 34 days, in group II within about 11 days, in group III within about 13 days. The fasting blood glucose levels in all 3 groups returned to normal 2 days after transplantation. Better results were achieved in the open-duct and Ethibloc-occluded grafts. 3 weeks after transplantation, a delayed and diminished increase of insulin concentration after glucose stimulation was observed compared to the dogs of the control group. Peak insulin values were significantly higher (p 0.01) in group I compared to group II. Histologically acinar atrophy with replacement by fibrous tissue occurred in all groups after 2 weeks. The least severe histological changes were observed in group II. The best results were achieved by the open-duct technique, whereas the occlusion groups showed a high rate of early complications like rejection, venous thrombosis and pancreatitis.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D010183 Pancreatic Ducts Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM. Duct of Santorini,Duct of Wirsung,Duodenal Papilla, Minor,Wirsung's Duct,Accessory Pancreatic Duct,Accessory Pancreatic Duct of Santorini,Main Pancreatic Duct,Santorini's Duct,Accessory Pancreatic Ducts,Duct, Accessory Pancreatic,Duct, Main Pancreatic,Duct, Pancreatic,Duct, Santorini's,Duct, Wirsung's,Ducts, Pancreatic,Main Pancreatic Ducts,Minor Duodenal Papilla,Minor Duodenal Papillas,Pancreatic Duct,Pancreatic Duct, Accessory,Pancreatic Duct, Main,Pancreatic Ducts, Accessory,Papilla, Minor Duodenal,Santorini Duct,Wirsung Duct,Wirsungs Duct
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004322 Drainage The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

O Abri, and D Lorenz, and H Lippert, and F Kühn
September 1983, The American surgeon,
O Abri, and D Lorenz, and H Lippert, and F Kühn
January 1982, Zentralblatt fur Chirurgie,
O Abri, and D Lorenz, and H Lippert, and F Kühn
October 1987, Transplantation proceedings,
O Abri, and D Lorenz, and H Lippert, and F Kühn
November 1986, Journal de chirurgie,
O Abri, and D Lorenz, and H Lippert, and F Kühn
April 1990, Transplantation proceedings,
O Abri, and D Lorenz, and H Lippert, and F Kühn
August 1965, Nihon rinsho. Japanese journal of clinical medicine,
O Abri, and D Lorenz, and H Lippert, and F Kühn
June 1992, Transplantation proceedings,
O Abri, and D Lorenz, and H Lippert, and F Kühn
January 2011, Clinical transplantation,
O Abri, and D Lorenz, and H Lippert, and F Kühn
June 1992, Transplantation proceedings,
O Abri, and D Lorenz, and H Lippert, and F Kühn
May 2000, Transplantation proceedings,
Copied contents to your clipboard!